IXICO plc (LON:IXI) Insider Grant Nash Purchases 45,263 Shares of Stock

IXICO plc (LON:IXI) insider Grant Nash acquired 45,263 shares of the company’s stock in a transaction that occurred on Thursday, June 12th. The shares were acquired at an average cost of GBX 13 ($0.18) per share, for a total transaction of £5,884.19 ($7,983.98).

IXICO Trading Down 6.2%

IXICO stock opened at GBX 11.49 ($0.16) on Friday. The company has a debt-to-equity ratio of 3.32, a current ratio of 2.85 and a quick ratio of 4.90. IXICO plc has a one year low of GBX 6.45 ($0.09) and a one year high of GBX 15 ($0.20). The stock has a market capitalization of £10.65 million, a PE ratio of -2.98, a price-to-earnings-growth ratio of -0.38 and a beta of 0.86. The business’s fifty day moving average is GBX 9.86 and its 200 day moving average is GBX 10.56.

IXICO (LON:IXI) last released its quarterly earnings data on Tuesday, May 20th. The company reported GBX (1.11) (($0.02)) EPS for the quarter. IXICO had a negative net margin of 31.10% and a negative return on equity of 19.14%. On average, sell-side analysts predict that IXICO plc will post -289.3584879 EPS for the current year.

About IXICO

IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.

By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.